What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“I have been able to work on a project focused on studying novel cell lines generated from patient with rare undifferentiated sarcomas in children, but also have had the opportunity to shadow in the clinic on a couple of occasions. This experience has awoken the idea of possibly pursing a career as a physician scientist and/or many other options that I had not considered in the past as career choices.”

Bryan Kynnap, Health Sciences, ’16


Trainee Spotlight


Catherine Nicholas

Health Science, '20

RHAMM splicing in multiple myeloma (MM) and its implications for immunotherapy

Jack Francisco

Health Science, '22

Integrated diffraction-based diagnostic for point-of-care screening

Aviv Liani

Biology, '21

Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia

Featured Trainee Publication


Upcoming Events

Local delivery of cancer immunotherapy: the example of cytokines

Friday, October 18, 2019

Stephanie Dougan, Ph.D. Assistant Professor, Microbiology and Immunobiology, Harvard Medical School

119 Snell Libary -- NEU, 3:25 PM


Mentor Spotlight


Ciprian Catana, M.D., Ph.D.

Associate Professor in Radiology , HMS

Our laboratory seeks to improve the quantification of the PET data using the simultaneously acquired MR information in integrated MR-PET scanners. Students will have the opportunity to use advanced MR-PET methods to study the delivery, mechanism of action and effects of therapeutic agents in cancer patients.


Ross I Berbeco, Ph.D.

Associate Professor of Radiation Oncology, HMS

Our lab performs theoretical and experimental studies of systemically administered nanoparticles and their role in enhancing radiation therapy for cancer treatment. Students will have the opportunity to functionalize these particles with tumor-specific targeting moieties and study how this leads to localized disruption of the tumor vasculature.


Trainee Spotlight


Sagi Ravid

Chemical Engineering, '21

Enhanced delivery of camptothecin and doxorubicin conjugates with hyaluronic acid for the treatment of Glioblastoma using microbubble-mediated focused ultrasound

Aviv Liani

Biology, '21

Impact of RPS15 mutation on development and progression of chronic lymphocytic leukemia

Jack Francisco

Health Science, '22

Integrated diffraction-based diagnostic for point-of-care screening


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...